Gastroprotection with proton-pump inhibitors in high-risk cardiovascular patients: who to target and for how long?

被引：3
|
作者：
Vaduganathan, Muthiah [1 ,2 ]
Pareek, Manan [1 ,2 ,3 ]
Bhatt, Deepak L. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, Dept Endocrinol, Cardiovasc & Metab Prevent Clin, Odense, Denmark
来源：
EXPERT OPINION ON DRUG SAFETY | 2016年 / 15卷 / 11期
关键词：
Cardiovascular safety; coronary artery disease; gastrointestinal bleeding; proton-pump inhibitors; LOW-DOSE ASPIRIN; DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY; CONSENSUS DOCUMENT; CLOPIDOGREL; TRIAL;
D O I：
10.1080/14740338.2016.1227790
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1451 / 1453
页数：3
相关论文
共 50 条
  • [1] Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial
    Vaduganathan, Muthiah
    Cannon, Christopher P.
    Cryer, Byron L.
    Liu, Yuyin
    Hsieh, Wen-Hua
    Doros, Gheorghe
    Cohen, Marc
    Lanas, Angel
    Schnitzer, Thomas J.
    Shook, Thomas L.
    Lapuerta, Pablo
    Goldsmith, Mark A.
    Laine, Loren
    Bhatt, Deepak L.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (09): : 1002 - 1005
  • [2] Proton-pump inhibitors as a protective treatment for high-risk patients receiving treatment with NSAIDs
    Francis KL Chan
    Nature Clinical Practice Rheumatology, 2007, 3 : 694 - 695
  • [3] Proton-pump inhibitors as a protective treatment for high-risk patients receiving treatment with NSAIDs
    Chan, Francis K. L.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (12): : 694 - 695
  • [4] Proton pump inhibitors: seeking the golden ratio between gastroprotection and cardiovascular risk
    Tsiartas, Eirinaios
    Papazoglou, Andreas S.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (05) : 420 - 421
  • [5] PRESCRIPTION OF PROTON-PUMP INHIBITORS IN PATIENTS WHO UNDERWENT TOTAL GASTRECTOMY
    Gramage Caro, Teresa
    Alvarez Diaz, Ana
    Rodriguez Vargas, Blanca
    Perez Menendez-Conde, Covadonga
    Delgado Silveira, Eva
    Bermejo Vicedo, Teresa
    ATENCION FARMACEUTICA, 2011, 13 (03): : 172 - 175
  • [6] Proton-Pump Inhibitors and Cardiovascular Risk (vol 153, pg 378, 2010)
    Charlot
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (01) : 76 - 76
  • [7] Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
    Qing Wang
    Rickard Ljung
    Jesper Lagergren
    Yunxia Lu
    BMC Pharmacology and Toxicology, 15
  • [8] Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
    Wang, Qing
    Ljung, Rickard
    Lagergren, Jesper
    Lu, Yunxia
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [9] INCIDENCE OF GASTROINTESTINAL BLEEDING IN HIGH-RISK CARDIOVASCULAR PATIENTS TAKING ANTITHROMBOTIC MEDICATIONS WITH PROTON PUMP INHIBITORS
    Edwards, Mark
    Kong, Xiaowen
    Kurlander, Jacob
    Kaatz, Scott
    Froehlich, James B.
    Tassava, Twylla
    Giuliano, Christopher
    Barnes, Geoffrey D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 100 : 42 - 43
  • [10] Microbial evaluation of proton-pump inhibitors and the risk of pneumonia
    Meijvis, S. C. A.
    Cornips, M. C. A.
    Voorn, G. P.
    Souverein, P. C.
    Endeman, H.
    Biesma, D. H.
    Leufkens, H. G. M.
    van de Garde, M. W.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (05) : 1165 - 1172
12345